Patents by Inventor Chuladatta Thenuwara

Chuladatta Thenuwara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230346638
    Abstract: An illustrative method may include 1) generating, by an implantable stimulator, stimulation sessions, wherein the implantable stimulator comprises a central electrode of a first polarity centrally located on a first surface of a housing of the implantable stimulator and an annular electrode of a second polarity and that is spaced apart from the central electrode; and 2) applying, by the implantable stimulator, the stimulation sessions by way of the central electrode and the annular electrode to a location within a patient.
    Type: Application
    Filed: June 20, 2023
    Publication date: November 2, 2023
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Publication number: 20230310861
    Abstract: An illustrative method of treating cardiovascular disease in a patient may include 1) generating, by an implantable stimulator, stimulation sessions, wherein the implantable stimulator comprises a central electrode of a first polarity centrally located on a first surface of a housing of the implantable stimulator and an annular electrode of a second polarity and that is spaced apart from the central electrode; and 2) applying, by the implantable stimulator, the stimulation sessions by way of the central electrode and the annular electrode to a location, within the patient, that is associated with the cardiovascular disease.
    Type: Application
    Filed: May 24, 2023
    Publication date: October 5, 2023
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara
  • Patent number: 11730673
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: August 22, 2023
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Patent number: 11730672
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery having an internal impedance greater than 5 ohms.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: August 22, 2023
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Patent number: 11707624
    Abstract: A method of treating cardiovascular disease in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a location, within the patient, that is associated with the cardiovascular disease. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: July 25, 2023
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara
  • Patent number: 11478403
    Abstract: A method of treating a mental disorder of a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a tissue location associated with the mental disorder. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: October 25, 2022
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy O. Greiner
  • Publication number: 20220323746
    Abstract: A method of treating hypertension includes an implantable stimulator generating stimulation sessions at a duty cycle that is less than 0.05 and applying the stimulation sessions by way of the central electrode and the annular electrode to a location associated with the hypertension and within a patient.
    Type: Application
    Filed: June 27, 2022
    Publication date: October 13, 2022
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara
  • Patent number: 11400278
    Abstract: A method of treating hypertension in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a tissue location associated with the hypertension. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: August 2, 2022
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara
  • Publication number: 20210268287
    Abstract: A method of treating cardiovascular disease in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a location, within the patient, that is associated with the cardiovascular disease. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.
    Type: Application
    Filed: May 18, 2021
    Publication date: September 2, 2021
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara
  • Patent number: 11013921
    Abstract: A method of treating cardiovascular disease in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a tissue location associated with the cardiovascular disease. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: May 25, 2021
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara
  • Patent number: 10940313
    Abstract: An exemplary method treating a chronic low back pain condition in a patient includes 1) generating, by an electroacupuncture device implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05, and 2) applying, by the electroacupuncture device in accordance with the duty cycle, the stimulation sessions to a target tissue location within the patient by way of an electrode array located within the patient at an acupoint corresponding to the target tissue location.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: March 9, 2021
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Patent number: 10940033
    Abstract: An exemplary method treating an erectile dysfunction condition in a patient includes 1) generating, by an electroacupuncture device implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05, and 2) applying, by the electroacupuncture device in accordance with the duty cycle, the stimulation sessions to a target tissue location within the patient by way of an electrode array located within the patient at an acupoint corresponding to the target tissue location.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: March 9, 2021
    Assignee: Valencia Bioscience, Inc.
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy O. Greiner
  • Publication number: 20210030621
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes.
    Type: Application
    Filed: October 21, 2020
    Publication date: February 4, 2021
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Publication number: 20210000687
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: September 23, 2020
    Publication date: January 7, 2021
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Patent number: 10792219
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: October 6, 2020
    Assignee: Valencia Technologies Corporation
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy O. Greiner
  • Publication number: 20200121917
    Abstract: A method of treating hypertension in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a tissue location associated with the hypertension. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: November 22, 2019
    Publication date: April 23, 2020
    Inventors: Jeffrey H. Greiner, David K.L. Peterson, Chuladatta Thenuwara
  • Patent number: 10518082
    Abstract: An electroacupuncture device for treating hypertension in a patient includes 1) a housing configured to be implanted beneath a skin surface of the patient at an acupoint corresponding to a target tissue location within the patient, the acupoint comprising at least one of PC5, PC6, ST36, and ST37, 2) a central electrode of a first polarity and centrally located and substantially planar on a first surface of the housing, 3) an annular electrode of a second polarity and that surrounds the central electrode on the first surface of the housing, the annular electrode being spaced apart from the central electrode, and 4) pulse generation circuitry located within the housing and electrically coupled to the annular and central electrodes.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: December 31, 2019
    Assignee: Valencia Technologies Corporation
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara
  • Publication number: 20190290541
    Abstract: A method of treating a mental disorder of a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a tissue location associated with the mental disorder. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: April 23, 2019
    Publication date: September 26, 2019
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy O. Greiner
  • Publication number: 20190247274
    Abstract: A method of treating cardiovascular disease in a patient includes generating, by an implantable stimulator configured to be implanted beneath a skin surface of the patient, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a tissue location associated with the cardiovascular disease. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: April 25, 2019
    Publication date: August 15, 2019
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara
  • Publication number: 20190247275
    Abstract: A method comprises generating, by an implantable stimulator, stimulation sessions at a duty cycle that is less than 0.05 and applying, by the implantable stimulator in accordance with the duty cycle, the stimulation sessions to a patient. The duty cycle is a ratio of T3 to T4. Each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes. The implantable stimulator is powered by a primary battery located within the implantable stimulator and having an internal impedance greater than 5 ohms.
    Type: Application
    Filed: April 25, 2019
    Publication date: August 15, 2019
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy O. Greiner